RT Journal Article
SR Electronic
A1 Jacobson, Anne
T1 Mitoglitazone and PPAR-Sparing Insulin Sensitizers
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 7
SP 17
OP 19
DO 10.1177/155989770800800708
UL http://mdc.sagepub.com/content/8/7/17.abstract
AB Activation of peroxisome proliferator-activated receptor (PPAR) is associated with dose-limiting side effects, such as edema and bone loss. This article describes recent efforts in the development of PPAR-sparing insulin sensitizers.